Home532296 • BOM
Glenmark Pharmaceuticals Ltd
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 32.68B | -16.11% |
Operating expense | 17.31B | 11.79% |
Net income | 46.50M | 100.38% |
Net profit margin | 0.14 | 100.45% |
Earnings per share | 7.21 | 125.58% |
EBITDA | 5.69B | -55.59% |
Effective tax rate | 45.02% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.05B | 2.47% |
Total assets | 160.50B | 11.78% |
Total liabilities | 72.00B | 10.59% |
Total equity | 88.49B | — |
Shares outstanding | 290.63M | — |
Price to book | 7.28 | — |
Return on assets | — | — |
Return on capital | 10.38% | — |
Cash Flow
Net Change in Cash
Net change in cash
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 46.50M | 100.38% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
₹2,218.20
Day range
₹2,170.80 - ₹2,234.55
Year range
₹1,274.70 - ₹2,286.15
Market cap
623.89B INR
Avg Volume
59.76K
P/E ratio
59.58
Dividend yield
-
Primary exchange
NSE
About
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Wikipedia
Founded
Nov 18, 1977
Website
Employees
14,989